Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain scans reveal how placebo cream eases pain

NCT ID NCT04653064

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study uses brain scans to explore how a placebo cream affects pain perception across different body sites. Researchers will apply a cream described as pain-relieving (though it is just a scrub) to healthy volunteers and measure their pain responses to heat. The goal is to understand how the brain represents pain and how placebos can reduce it, which may inform future non-drug pain treatments.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
placebo cream (exfoliating skin scrub)
What this could lead to
If successful, this could improve understanding of how placebos reduce pain, potentially leading to better non-drug pain management strategies.
What could go wrong
This is an early-stage, small study focused on brain mechanisms, not a treatment trial. The placebo effect is well-known but often inconsistent, and results may not translate to real-world pain relief.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2021

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subject must be a volunteer with a minimum age of 18 years and must be able and willing to provide written informed consent. * If female, the subject must be non-lactating, not pregnant, and using a reliable contraception method. * Subject must be able to read and speak English. * Subject must be able to understand and follow the instructions of the investigator and understand all screening questionnaires. * Subject must have no current or recent history of pathological pain. * Subject must have abstained from alcohol and substance use for 48 hours. * Subject must pass all fMRI screening tests. Exclusion Criteria: * If female, pregnancy. * Inability to tolerate the scanning procedures (e.g., claustrophobia). * Metal in body or prior history working with metal fragments (e.g., as a machinist). * Inability to tolerate heat pain applied to the forearm. * Reporting temporary abnormal levels of pain. * Allergic response to the exfoliating cream. * Current presence of pain. * Current or past history of psychoactive substance abuse or dependence. * Dementias. * Movement disorders except familial tremor. * CNS infection. * CNS vasculitis. * Inflammatory disease or autoimmune disease. * CNS demyelinating disease (e.g. multiple sclerosis). * Space occupying lesions (mass lesions, tumors). * Congenital CNS abnormality (e.g. cerebral palsy). * Seizure disorder. * History of closed head trauma with loss of consciousness. * History of cerebrovascular disease (stroke, TIAs). * Abnormal MRI (except changes accounted for by technical factors or UBOs. * Neuroendocrine disorders (e.g., Cushings disease). * Uncorrected hypothyroidism or hyperthyroidism. * Current or past history of cancer. * Recent history (within two years) of myocardial infarction, severe cardiovascular disease, or currently active cardiovascular disease (e.g. angina, cardiomyopathy). * Uncontrolled hypertension or hypotension. * Chronic pain syndromes. * Chronic fatigue syndromes. * A history of neurologic disease or neuropathic pain. * Prior treatment within the last month with any of the following: antidepressants, mood stabilizers, glucocorticoids, opiates. * Prior treatment with any of the following: antipsychotics, isoniazid, centrally active antihypertensive drugs (e.g. clonidine, reserpine). * Any other contraindications for MRI examination (e.g., metallic implants such as pacemakers, surgical aneurysm clips, or known metal fragments embedded in the body). * Current treatment for psychiatric disorders including mood, anxiety, substance abuse, attention-deficit/hyperactivity disorder (ADHD), psychosis. * Neurological disorders (e.g., taking dopamine agonists for Parkinson's) Cardiovascular disease or medication (e.g., taking ACE (angiotensin-converting-enzyme) inhibitors for cardiac remodeling). * Frequent smoking (\> 5 cigarettes / day). * Frequent alcohol use (\> 14 drinks / week). * Frequent migraines (\> 5 / month on average).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Dartmouth College

    RECRUITING

    Hanover, New Hampshire, 03755, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.